Article No
BE0338-1MG
InVivoMAb anti-human CD220 (Insulin Receptor)
InVivoMAb anti-human CD220 (Insulin Receptor)
Antibodies Primary
Specifications
| MW | 150 kDa |
| Application | WB |
| Article No | BE0338-1MG |
| Country Availability | SE, FI, DK, NO, EE, LV, LT |
| Clone | IR 83-22 |
| Clone Type | monoclonal |
| Concentration | 4-11 mg/ml |
| Conjugation | Unconjugated |
| Description | InVivoMAb anti-human CD220 (Insulin Receptor) |
| Supplier | BioXCell |
| Endotoxin | <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay|InVivoMAb |
| Immunogen | Human IM-9 lymphocytes |
| Isotype | IgG1 |
| Product Type | Antibodies Primary |
| Purity | >95% |
| Shipping Information | BLUE ICE |
| Size | 1 mg |
| Source / Host | mouse |
| Species Reactivity | human |
| Storage | 4°C |
| Product Page Updated | 2024-03-25T10:15:09.827Z |
